Literature DB >> 6341514

Pharmacologic alterations in Tc-99m binding by red blood cells: concise communication.

H B Lee, J P Wexler, S C Scharf, M D Blaufox.   

Abstract

The effect of two antihypertensive agents (captopril and prazosin) and of digoxin on the efficiency of Tc-99m binding to RBCs was evaluated in the rat. RBCs were labeled with Tc-99m in vivo in six groups of rats: I-normotensive controls Wistar rat (WR), II-prazosin treated WR, III-spontaneously hypertensive rat (SHR), IV-prazosin-treated SHR, V-digoxin-treated WR, and VI-captopril-treated WR. The percentage of intravascular Tc-99m bound to RBC (%T) and the percentage of injected dose remaining intravascular 5 min after injection (%i.v.) were determined. Mean %T was 94.2, 83.8, 94.9, 86.1, 79.7, and 93.3 for groups I-VI respectively. Mean %I.V. was 96.4, 74.6, 94.9, 79.0, 74.4, and 87.4 for groups I-VI respectively. The findings demonstrate a significant reduction of RBC tagging with Tc-99m in rats treated with prazosin and digoxin but not with captopril. The data suggest a potential interference by patient medication with the performance of blood-pool studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341514

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  EANM/ESC guidelines for radionuclide imaging of cardiac function.

Authors:  B Hesse; T B Lindhardt; W Acampa; C Anagnostopoulos; J Ballinger; J J Bax; L Edenbrandt; A Flotats; G Germano; T Gmeiner Stopar; P Franken; A Kelion; A Kjaer; D Le Guludec; M Ljungberg; A F Maenhout; C Marcassa; J Marving; F McKiddie; W M Schaefer; L Stegger; R Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04       Impact factor: 9.236

2.  Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations.

Authors:  A S Hambye; R Vandermeiren; A Vervaet; J Vandevivere
Journal:  Eur J Nucl Med       Date:  1995-01

3.  A new 99mTc-red blood cell labeling procedure for cardiac blood pool imaging: clinical results.

Authors:  H Kelbaek; K Bülow; J Aldershvile; J Møgelvang; S L Nielsen
Journal:  Eur J Nucl Med       Date:  1989

Review 4.  Poor-quality red blood cell labelling with technetium-99m: case report and review of the literature.

Authors:  I Adalet; S Cantez
Journal:  Eur J Nucl Med       Date:  1994-02

Review 5.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

Review 6.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

7.  Can technetium 99m bisdiethylphosphinoethanebis-t butylisocyanide (99mTc-DEPIC) be used for routine radionuclide ventriculography?

Authors:  J M de Klerk; P P van Rijk; A J van Dongen; M Deenstra; J H Bànki; A D van het Schip
Journal:  Eur J Nucl Med       Date:  1991

8.  Animal and human studies of a new 99mTc labelled phosphine-isocyanide complex with possible applications to radionuclide ventriculography.

Authors:  G D Zanelli; A Lahiri; N Patel; T Smith; F Brady; G Radfar; N D Cook; J C Crawley; D J Silvester
Journal:  Eur J Nucl Med       Date:  1987
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.